JPMorgan Healthcare Leaders ETF (JDOC)

Assets	$8.77M
Expense Ratio	0.65%
PE Ratio	24.87
Shares Out	150,000
Dividend (ttm)	$0.51
Dividend Yield	0.87%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Semi-Annual
Payout Ratio	22.01%

Volume	267
Open	58.90
Previous Close	57.85
Day's Range	58.90 - 58.90
52-Week Low	47.67
52-Week High	59.69
Beta	0.62
Holdings	66
Inception Date	Nov 1, 2023

About JDOC

Fund Home Page

The JPMorgan Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: JDOC
• ETF Provider: JPMorgan Chase

Top 10 Holdings

46.48% of assets

Name	Symbol	Weight
Johnson & Johnson	JNJ	8.52%
Eli Lilly and Company	LLY	7.29%
AbbVie Inc.	ABBV	5.65%
Merck & Co., Inc.	MRK	4.93%
AstraZeneca PLC	AZN	4.89%
UnitedHealth Group Incorporated	UNH	3.34%
Medtronic plc	MDT	3.08%
Roche Holding AG	ROG	2.95%
Danaher Corporation	DHR	2.92%
Novo Nordisk A/S	NOVO.B	2.91%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.5121	Dec 18, 2025
Dec 24, 2024	$0.3276	Dec 27, 2024
Dec 16, 2024	$2.48902	Dec 18, 2024
Dec 19, 2023	$0.07965	Dec 22, 2023

Performance

JDOC had a total return of 7.24% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.53%.